Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 188 entries
Sorted by: Best Match Show Resources per page
Tissue Engineering and Regenerative Medicine: New Trends and Directions-A Year in Review.

Tissue engineering. Part B, Reviews

Gomes ME, Rodrigues MT, Domingues RMA, Reis RL.
PMID: 28457175
Tissue Eng Part B Rev. 2017 Jun;23(3):211-224. doi: 10.1089/ten.TEB.2017.0081.

Tissue engineering (TE) is continuously evolving assimilating inputs from adjacent scientific areas and their technological advances, including nanotechnology developments that have been spawning the range of available options for the precise manipulation and control of cells and cellular environments....

Cite
Gomes ME, Rodrigues MT, Domingues RMA, et al. Tissue Engineering and Regenerative Medicine: New Trends and Directions-A Year in Review. Tissue Eng Part B Rev. 2017;23(3):211-224doi: 10.1089/ten.TEB.2017.0081.
Gomes, M. E., Rodrigues, M. T., Domingues, R. M. A., & Reis, R. L. (2017). Tissue Engineering and Regenerative Medicine: New Trends and Directions-A Year in Review. Tissue engineering. Part B, Reviews, 23(3), 211-224. https://doi.org/10.1089/ten.TEB.2017.0081
Gomes, Manuela E, et al. "Tissue Engineering and Regenerative Medicine: New Trends and Directions-A Year in Review." Tissue engineering. Part B, Reviews vol. 23,3 (2017): 211-224. doi: https://doi.org/10.1089/ten.TEB.2017.0081
Gomes ME, Rodrigues MT, Domingues RMA, Reis RL. Tissue Engineering and Regenerative Medicine: New Trends and Directions-A Year in Review. Tissue Eng Part B Rev. 2017 Jun;23(3):211-224. doi: 10.1089/ten.TEB.2017.0081. PMID: 28457175.
Copy Download .nbib Format: NLM
Regenerative Medicine for Dentistry-"Times are A-Changin".

The Journal of oral implantology

Rutkowski JL.
PMID: 26070076
J Oral Implantol. 2015 Jun;41(3):234. doi: 10.1563/AAID-JOI-D-15-Editorial.4103.

No abstract available.

Cite
Rutkowski JL. Regenerative Medicine for Dentistry-"Times are A-Changin". J Oral Implantol. 2015;41(3):234doi: 10.1563/AAID-JOI-D-15-Editorial.4103.
Rutkowski, J. L. (2015). Regenerative Medicine for Dentistry-"Times are A-Changin". The Journal of oral implantology, 41(3), 234. https://doi.org/10.1563/AAID-JOI-D-15-Editorial.4103
Rutkowski, James L. "Regenerative Medicine for Dentistry-"Times are A-Changin"." The Journal of oral implantology vol. 41,3 (2015): 234. doi: https://doi.org/10.1563/AAID-JOI-D-15-Editorial.4103
Rutkowski JL. Regenerative Medicine for Dentistry-"Times are A-Changin". J Oral Implantol. 2015 Jun;41(3):234. doi: 10.1563/AAID-JOI-D-15-Editorial.4103. PMID: 26070076.
Copy Download .nbib Format: NLM
Stem cells as drug delivery methods: application of stem cell secretome for regeneration.

Advanced drug delivery reviews

Tran C, Damaser MS.
PMID: 25451858
Adv Drug Deliv Rev. 2015 Mar;82:1-11. doi: 10.1016/j.addr.2014.10.007. Epub 2014 Oct 15.

Mesenchymal stem cells (MSCs) are a unique cell population defined by their ability to indefinitely self-renew, differentiate into multiple cell lineages, and form clonal cell populations. It was originally thought that this ability for broad plasticity defined the therapeutic...

Cite
Tran C, Damaser MS. Stem cells as drug delivery methods: application of stem cell secretome for regeneration. Adv Drug Deliv Rev. 2014;82:1-11doi: 10.1016/j.addr.2014.10.007.
Tran, C., & Damaser, M. S. (2015). Stem cells as drug delivery methods: application of stem cell secretome for regeneration. Advanced drug delivery reviews, 821-11. https://doi.org/10.1016/j.addr.2014.10.007
Tran, Christine, and Damaser, Margot S. "Stem cells as drug delivery methods: application of stem cell secretome for regeneration." Advanced drug delivery reviews vol. 82 (2015): 1-11. doi: https://doi.org/10.1016/j.addr.2014.10.007
Tran C, Damaser MS. Stem cells as drug delivery methods: application of stem cell secretome for regeneration. Adv Drug Deliv Rev. 2015 Mar;82:1-11. doi: 10.1016/j.addr.2014.10.007. Epub 2014 Oct 15. PMID: 25451858; PMCID: PMC4398586.
Copy Download .nbib Format: NLM
Advances in tissue engineering.

Journal of pediatric surgery

Langer R, Vacanti J.
PMID: 26711689
J Pediatr Surg. 2016 Jan;51(1):8-12. doi: 10.1016/j.jpedsurg.2015.10.022. Epub 2015 Nov 10.

Nearly 30 years ago, we reported on a concept now known as Tissue Engineering. Here, we report on some of the advances in this now thriving area of research. In particular, significant advances in tissue engineering of skin, liver,...

Cite
Langer R, Vacanti J. Advances in tissue engineering. J Pediatr Surg. 2015;51(1):8-12doi: 10.1016/j.jpedsurg.2015.10.022.
Langer, R., & Vacanti, J. (2016). Advances in tissue engineering. Journal of pediatric surgery, 51(1), 8-12. https://doi.org/10.1016/j.jpedsurg.2015.10.022
Langer, Robert, and Vacanti, Joseph. "Advances in tissue engineering." Journal of pediatric surgery vol. 51,1 (2016): 8-12. doi: https://doi.org/10.1016/j.jpedsurg.2015.10.022
Langer R, Vacanti J. Advances in tissue engineering. J Pediatr Surg. 2016 Jan;51(1):8-12. doi: 10.1016/j.jpedsurg.2015.10.022. Epub 2015 Nov 10. PMID: 26711689; PMCID: PMC4733916.
Copy Download .nbib Format: NLM
Regenerative medicine: is this the biggest change in surgery?.

Seminars in pediatric surgery

De Coppi P, Grikscheit TC.
PMID: 24994522
Semin Pediatr Surg. 2014 Jun;23(3):103-5. doi: 10.1053/j.sempedsurg.2014.04.001. Epub 2014 Apr 18.

No abstract available.

Cite
De Coppi P, Grikscheit TC. Regenerative medicine: is this the biggest change in surgery?. Semin Pediatr Surg. 2014;23(3):103-5doi: 10.1053/j.sempedsurg.2014.04.001.
De Coppi, P., & Grikscheit, T. C. (2014). Regenerative medicine: is this the biggest change in surgery?. Seminars in pediatric surgery, 23(3), 103-5. https://doi.org/10.1053/j.sempedsurg.2014.04.001
De Coppi, Paolo, and Grikscheit, T C. "Regenerative medicine: is this the biggest change in surgery?." Seminars in pediatric surgery vol. 23,3 (2014): 103-5. doi: https://doi.org/10.1053/j.sempedsurg.2014.04.001
De Coppi P, Grikscheit TC. Regenerative medicine: is this the biggest change in surgery?. Semin Pediatr Surg. 2014 Jun;23(3):103-5. doi: 10.1053/j.sempedsurg.2014.04.001. Epub 2014 Apr 18. PMID: 24994522.
Copy Download .nbib Format: NLM
Mesenchymal stem cells and their subpopulation, pluripotent muse cells, in basic research and regenerative medicine.

Anatomical record (Hoboken, N.J. : 2007)

Kuroda Y, Dezawa M.
PMID: 24293378
Anat Rec (Hoboken). 2014 Jan;297(1):98-110. doi: 10.1002/ar.22798. Epub 2013 Dec 02.

Mesenchymal stem cells (MSCs) have gained a great deal of attention for regenerative medicine because they can be obtained from easy accessible mesenchymal tissues, such as bone marrow, adipose tissue, and the umbilical cord, and have trophic and immunosuppressive...

Cite
Kuroda Y, Dezawa M. Mesenchymal stem cells and their subpopulation, pluripotent muse cells, in basic research and regenerative medicine. Anat Rec (Hoboken). 2013;297(1):98-110doi: 10.1002/ar.22798.
Kuroda, Y., & Dezawa, M. (2014). Mesenchymal stem cells and their subpopulation, pluripotent muse cells, in basic research and regenerative medicine. Anatomical record (Hoboken, N.J. : 2007), 297(1), 98-110. https://doi.org/10.1002/ar.22798
Kuroda, Yasumasa, and Dezawa, Mari. "Mesenchymal stem cells and their subpopulation, pluripotent muse cells, in basic research and regenerative medicine." Anatomical record (Hoboken, N.J. : 2007) vol. 297,1 (2014): 98-110. doi: https://doi.org/10.1002/ar.22798
Kuroda Y, Dezawa M. Mesenchymal stem cells and their subpopulation, pluripotent muse cells, in basic research and regenerative medicine. Anat Rec (Hoboken). 2014 Jan;297(1):98-110. doi: 10.1002/ar.22798. Epub 2013 Dec 02. PMID: 24293378.
Copy Download .nbib Format: NLM
[Somatic stem cell therapy for mitochondrial diseases].

Tanpakushitsu kakusan koso. Protein, nucleic acid, enzyme

Inoue S.
PMID: 16318356
Tanpakushitsu Kakusan Koso. 2005 Nov;50(14):1907-8.

No abstract available.

Cite
Inoue S. [Somatic stem cell therapy for mitochondrial diseases]. Tanpakushitsu Kakusan Koso. 2005;50(14):1907-8
Inoue, S. (2005). [Somatic stem cell therapy for mitochondrial diseases]. Tanpakushitsu kakusan koso. Protein, nucleic acid, enzyme, 50(14), 1907-8.
Inoue, Shin-Ichi. "[Somatic stem cell therapy for mitochondrial diseases]." Tanpakushitsu kakusan koso. Protein, nucleic acid, enzyme vol. 50,14 (2005): 1907-8.
Inoue S. [Somatic stem cell therapy for mitochondrial diseases]. Tanpakushitsu Kakusan Koso. 2005 Nov;50(14):1907-8. Japanese. PMID: 16318356.
Copy Download .nbib Format: NLM
American Society for Artificial Internal Organs: the government's role in advancing regenerative medicine and tissue engineering.

ASAIO journal (American Society for Artificial Internal Organs : 1992)

Zucker HA.
PMID: 15672773
ASAIO J. 2004 Nov-Dec;50(6):xix-xxi. doi: 10.1097/01.mat.0000147888.62077.71.

No abstract available.

Cite
Zucker HA. American Society for Artificial Internal Organs: the government's role in advancing regenerative medicine and tissue engineering. ASAIO J. 2004;50(6):xix-xxidoi: 10.1097/01.mat.0000147888.62077.71.
Zucker, H. A. (2004). American Society for Artificial Internal Organs: the government's role in advancing regenerative medicine and tissue engineering. ASAIO journal (American Society for Artificial Internal Organs : 1992), 50(6), xix-xxi. https://doi.org/10.1097/01.mat.0000147888.62077.71
Zucker, Howard A. "American Society for Artificial Internal Organs: the government's role in advancing regenerative medicine and tissue engineering." ASAIO journal (American Society for Artificial Internal Organs : 1992) vol. 50,6 (2004): xix-xxi. doi: https://doi.org/10.1097/01.mat.0000147888.62077.71
Zucker HA. American Society for Artificial Internal Organs: the government's role in advancing regenerative medicine and tissue engineering. ASAIO J. 2004 Nov-Dec;50(6):xix-xxi. doi: 10.1097/01.mat.0000147888.62077.71. PMID: 15672773.
Copy Download .nbib Format: NLM
Nanotechnology in ophthalmology.

Canadian journal of ophthalmology. Journal canadien d'ophtalmologie

Zarbin MA, Montemagno C, Leary JF, Ritch R.
PMID: 20871642
Can J Ophthalmol. 2010 Oct;45(5):457-76. doi: 10.3129/i10-090.

Nanotechnology involves the creation and use of materials and devices at the size scale of intracellular structures and molecules, and involves systems and constructs in the order of

Cite
Zarbin MA, Montemagno C, Leary JF, et al. Nanotechnology in ophthalmology. Can J Ophthalmol. 2010;45(5):457-76doi: 10.3129/i10-090.
Zarbin, M. A., Montemagno, C., Leary, J. F., & Ritch, R. (2010). Nanotechnology in ophthalmology. Canadian journal of ophthalmology. Journal canadien d'ophtalmologie, 45(5), 457-76. https://doi.org/10.3129/i10-090
Zarbin, Marco A, et al. "Nanotechnology in ophthalmology." Canadian journal of ophthalmology. Journal canadien d'ophtalmologie vol. 45,5 (2010): 457-76. doi: https://doi.org/10.3129/i10-090
Zarbin MA, Montemagno C, Leary JF, Ritch R. Nanotechnology in ophthalmology. Can J Ophthalmol. 2010 Oct;45(5):457-76. doi: 10.3129/i10-090. PMID: 20871642.
Copy Download .nbib Format: NLM
Abstracts of the 3rd World Congress on Regenerative Medicine, October 18-20, 2007, Leipzig, Germany.

Regenerative medicine

[No authors listed]
PMID: 17941763
Regen Med. 2007 Sep;2(5):485-740. doi: 10.2217/17460751.2.5.485.

No abstract available.

Cite
Abstracts of the 3rd World Congress on Regenerative Medicine, October 18-20, 2007, Leipzig, Germany. Regen Med. 2007;2(5):485-740doi: 10.2217/17460751.2.5.485.
(2007). Abstracts of the 3rd World Congress on Regenerative Medicine, October 18-20, 2007, Leipzig, Germany. Regenerative medicine, 2(5), 485-740. https://doi.org/10.2217/17460751.2.5.485
"Abstracts of the 3rd World Congress on Regenerative Medicine, October 18-20, 2007, Leipzig, Germany." Regenerative medicine vol. 2,5 (2007): 485-740. doi: https://doi.org/10.2217/17460751.2.5.485
Abstracts of the 3rd World Congress on Regenerative Medicine, October 18-20, 2007, Leipzig, Germany. Regen Med. 2007 Sep;2(5):485-740. doi: 10.2217/17460751.2.5.485. PMID: 17941763.
Copy Download .nbib Format: NLM
The regenerative medicine coalition. Interview with Frank-Roman Lauter.

Regenerative medicine

Lauter FR.
PMID: 23210813
Regen Med. 2012 Nov;7(6):69-70. doi: 10.2217/rme.12.86.

Frank-Roman Lauter, Secretary General of the recently launched Regenerative Medicine Coalition, explains how the coalition was formed and what they hope to achieve. Frank-Roman Lauter has served as Secretary General of the Regenerative Medicine Coalition since 2012, and as...

Cite
Lauter FR. The regenerative medicine coalition. Interview with Frank-Roman Lauter. Regen Med. 2012;7(6):69-70doi: 10.2217/rme.12.86.
Lauter, F. R. (2012). The regenerative medicine coalition. Interview with Frank-Roman Lauter. Regenerative medicine, 7(6), 69-70. https://doi.org/10.2217/rme.12.86
Lauter, Frank-Roman. "The regenerative medicine coalition. Interview with Frank-Roman Lauter." Regenerative medicine vol. 7,6 (2012): 69-70. doi: https://doi.org/10.2217/rme.12.86
Lauter FR. The regenerative medicine coalition. Interview with Frank-Roman Lauter. Regen Med. 2012 Nov;7(6):69-70. doi: 10.2217/rme.12.86. PMID: 23210813.
Copy Download .nbib Format: NLM
Peers call for UK to harness "enormous" potential of regenerative medicine.

BMJ (Clinical research ed.)

O'Dowd A.
PMID: 23818565
BMJ. 2013 Jul 01;347:f4248. doi: 10.1136/bmj.f4248.

No abstract available.

Cite
O'Dowd A. Peers call for UK to harness "enormous" potential of regenerative medicine. BMJ. 2013;347:f4248doi: 10.1136/bmj.f4248.
O'Dowd, A. (2013). Peers call for UK to harness "enormous" potential of regenerative medicine. BMJ (Clinical research ed.), 347f4248. https://doi.org/10.1136/bmj.f4248
O'Dowd, Adrian. "Peers call for UK to harness "enormous" potential of regenerative medicine." BMJ (Clinical research ed.) vol. 347 (2013): f4248. doi: https://doi.org/10.1136/bmj.f4248
O'Dowd A. Peers call for UK to harness "enormous" potential of regenerative medicine. BMJ. 2013 Jul 01;347:f4248. doi: 10.1136/bmj.f4248. PMID: 23818565.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 188 entries